| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Enhanced brain drug delivery: safely crossing the blood–brain barrier
|
Gaillard, Pieter J.
|
|
2012
|
9 |
2 |
p. e155-e160
nvt p.
|
artikel
|
| 2 |
Enhanced permeability and retention effect for selective targeting of anticancer nanomedicine: are we there yet?
|
Greish, Khaled
|
|
2012
|
9 |
2 |
p. e161-e166
nvt p.
|
artikel
|
| 3 |
Formulation technologies to overcome poor drug-like properties
|
Alfredson, Tom
|
|
2012
|
9 |
2 |
p. e71-e72
nvt p.
|
artikel
|
| 4 |
Formulation technologies to overcome unfavorable properties of peptides and proteins for pulmonary delivery
|
Wan, Feng
|
|
2012
|
9 |
2 |
p. e141-e146
nvt p.
|
artikel
|
| 5 |
Insight of current technologies for oral delivery of proteins and peptides
|
Chin, Jungwook
|
|
2012
|
9 |
2 |
p. e105-e112
nvt p.
|
artikel
|
| 6 |
Lipid-based formulations for oral delivery of lipophilic drugs
|
Kuentz, Martin
|
|
2012
|
9 |
2 |
p. e97-e104
nvt p.
|
artikel
|
| 7 |
Optimizing the physical form – opportunities and limitations
|
Byrn, Stephen R.
|
|
2012
|
9 |
2 |
p. e73-e78
nvt p.
|
artikel
|
| 8 |
Overcoming poor oral bioavailability using nanoparticle formulations – opportunities and limitations
|
Desai, Preshita P.
|
|
2012
|
9 |
2 |
p. e87-e95
nvt p.
|
artikel
|
| 9 |
Overcoming poor permeability – the role of prodrugs for oral drug delivery
|
Maag, Hans
|
|
2012
|
9 |
2 |
p. e121-e130
nvt p.
|
artikel
|
| 10 |
Overcoming poor permeability: translating permeation enhancers for oral peptide delivery
|
Maher, Sam
|
|
2012
|
9 |
2 |
p. e113-e119
nvt p.
|
artikel
|
| 11 |
Peptide and protein transdermal drug delivery
|
Herwadkar, Anushree
|
|
2012
|
9 |
2 |
p. e147-e154
nvt p.
|
artikel
|
| 12 |
siRNA as a conventional drug in the clinic? Challenges and current technologies
|
Shim, Min Suk
|
|
2012
|
9 |
2 |
p. e167-e173
nvt p.
|
artikel
|
| 13 |
Smart polymers for peptide and protein parenteral sustained delivery
|
Oak, Mayura
|
|
2012
|
9 |
2 |
p. e131-e140
nvt p.
|
artikel
|
| 14 |
The use of amorphous solid dispersions: A formulation strategy to overcome poor solubility and dissolution rate
|
Van den Mooter, Guy
|
|
2012
|
9 |
2 |
p. e79-e85
nvt p.
|
artikel
|
Tijdschrift beschrijving